116 related articles for article (PubMed ID: 38818582)
1. COL5A2 drives regorafenib resistance-induced metastatic phenotype via reducing LIFR expression in hepatocellular carcinoma.
Zhang S; Xue X; Chen F; Yang Y; Zhang N; Chen Y; Wu W; Wang J; Zheng N
Acta Biochim Biophys Sin (Shanghai); 2024 May; ():. PubMed ID: 38818582
[TBL] [Abstract][Full Text] [Related]
2. Regorafenib inhibits migration, invasion, and vasculogenic mimicry of hepatocellular carcinoma via targeting ID1-mediated EMT.
Zhang N; Zhang S; Wu W; Lu W; Jiang M; Zheng N; Huang J; Wang L; Liu H; Zheng M; Wang J
Mol Carcinog; 2021 Feb; 60(2):151-163. PubMed ID: 33428809
[TBL] [Abstract][Full Text] [Related]
3. Pin1 inhibition reverses the acquired resistance of human hepatocellular carcinoma cells to Regorafenib via the Gli1/Snail/E-cadherin pathway.
Wang J; Zhang N; Han Q; Lu W; Wang L; Yang D; Zheng M; Zhang Z; Liu H; Lee TH; Zhou XZ; Lu KP
Cancer Lett; 2019 Mar; 444():82-93. PubMed ID: 30583078
[TBL] [Abstract][Full Text] [Related]
4. Changes in Wnt and TGF-β Signaling Mediate the Development of Regorafenib Resistance in Hepatocellular Carcinoma Cell Line HuH7.
Karabicici M; Azbazdar Y; Ozhan G; Senturk S; Firtina Karagonlar Z; Erdal E
Front Cell Dev Biol; 2021; 9():639779. PubMed ID: 34458250
[TBL] [Abstract][Full Text] [Related]
5. Regulatory mechanisms and therapeutic targeting of vasculogenic mimicry in hepatocellular carcinoma.
Zheng N; Zhang S; Wu W; Zhang N; Wang J
Pharmacol Res; 2021 Apr; 166():105507. PubMed ID: 33610718
[TBL] [Abstract][Full Text] [Related]
6. Expression and functional significance of Twist1 in hepatocellular carcinoma: its role in vasculogenic mimicry.
Sun T; Zhao N; Zhao XL; Gu Q; Zhang SW; Che N; Wang XH; Du J; Liu YX; Sun BC
Hepatology; 2010 Feb; 51(2):545-56. PubMed ID: 19957372
[TBL] [Abstract][Full Text] [Related]
7. Androgen receptor suppresses vasculogenic mimicry in hepatocellular carcinoma via circRNA7/miRNA7-5p/VE-cadherin/Notch4 signalling.
Bao S; Jin S; Wang C; Tu P; Hu K; Lu J
J Cell Mol Med; 2020 Dec; 24(23):14110-14120. PubMed ID: 33118329
[TBL] [Abstract][Full Text] [Related]
8. CD276 Promotes Vasculogenic Mimicry Formation in Hepatocellular Carcinoma via the PI3K/AKT/MMPs Pathway.
Cheng R; Wang B; Cai XR; Chen ZS; Du Q; Zhou LY; Ye JM; Chen YL
Onco Targets Ther; 2020; 13():11485-11498. PubMed ID: 33204103
[TBL] [Abstract][Full Text] [Related]
9. miR-221-3p regulates hepatocellular carcinoma cell proliferation, migration and invasion via targeting LIFR.
Tan W; Li Z; Xia W; Zhu J; Fan R
Ann Hepatol; 2022 Jan; 27 Suppl 1():100567. PubMed ID: 34699986
[TBL] [Abstract][Full Text] [Related]
10. LIFR functions as a metastasis suppressor in hepatocellular carcinoma by negatively regulating phosphoinositide 3-kinase/AKT pathway.
Luo Q; Wang C; Jin G; Gu D; Wang N; Song J; Jin H; Hu F; Zhang Y; Ge T; Huo X; Chu W; Shu H; Fang J; Yao M; Gu J; Cong W; Qin W
Carcinogenesis; 2015 Oct; 36(10):1201-12. PubMed ID: 26249360
[TBL] [Abstract][Full Text] [Related]
11. TOP2A inhibition reverses drug resistance of hepatocellular carcinoma to regorafenib.
Wang Z; Zhu Q; Li X; Ren X; Li J; Zhang Y; Zeng S; Xu L; Dong X; Zhai B
Am J Cancer Res; 2022; 12(9):4343-4360. PubMed ID: 36225636
[TBL] [Abstract][Full Text] [Related]
12. Targeting SphK2 Reverses Acquired Resistance of Regorafenib in Hepatocellular Carcinoma.
Shi W; Zhang S; Ma D; Yan D; Zhang G; Cao Y; Wang Z; Wu J; Jiang C
Front Oncol; 2020; 10():694. PubMed ID: 32670862
[No Abstract] [Full Text] [Related]
13. A feedback loop of PPP and PI3K/AKT signal pathway drives regorafenib-resistance in HCC.
Yang H; Chen D; Wu Y; Zhou H; Diao W; Liu G; Li Q
Cancer Metab; 2023 Dec; 11(1):27. PubMed ID: 38111012
[TBL] [Abstract][Full Text] [Related]
14. miR-215-5p Plays a Key Role in Suppressing Vascular Invasion and Recurrence in Hepatocellular Carcinoma by Blocking Vasculogenic Mimicry.
Zhang H; Lan X; Cai L; Gao X; Gao F; Yu D; Zhang J; Zhang J; Tai Q
Front Biosci (Elite Ed); 2024 Feb; 16(1):6. PubMed ID: 38538524
[TBL] [Abstract][Full Text] [Related]
15. lncRNA LIFR-AS1 suppresses invasion and metastasis of non-small cell lung cancer via the miR-942-5p/ZNF471 axis.
Wang Q; Wu J; Huang H; Jiang Y; Huang Y; Fang H; Zheng G; Zhou X; Wu Y; Lei C; Hu D
Cancer Cell Int; 2020; 20():180. PubMed ID: 32489316
[TBL] [Abstract][Full Text] [Related]
16. Implications of Withaferin A for the metastatic potential and drug resistance in hepatocellular carcinoma cells via Nrf2-mediated EMT and ferroptosis.
Zhang Y; Tan Y; Liu S; Yin H; Duan J; Fan L; Zhao X; Jiang B
Toxicol Mech Methods; 2023 Jan; 33(1):47-55. PubMed ID: 35592903
[TBL] [Abstract][Full Text] [Related]
17. MTDH in macrophages promotes the vasculogenic mimicry via VEGFA-165/Flt-1 signaling pathway in head and neck squamous cell carcinoma.
Liu X; Lv Z; Zhou S; Kan S; Liu X; Jing P; Xu W
Int Immunopharmacol; 2021 Jul; 96():107776. PubMed ID: 34162144
[TBL] [Abstract][Full Text] [Related]
18. HIF-1α promoted vasculogenic mimicry formation in hepatocellular carcinoma through LOXL2 up-regulation in hypoxic tumor microenvironment.
Wang M; Zhao X; Zhu D; Liu T; Liang X; Liu F; Zhang Y; Dong X; Sun B
J Exp Clin Cancer Res; 2017 Apr; 36(1):60. PubMed ID: 28449718
[TBL] [Abstract][Full Text] [Related]
19. Hsp90β promotes aggressive vasculogenic mimicry via epithelial-mesenchymal transition in hepatocellular carcinoma.
Meng J; Chen S; Lei YY; Han JX; Zhong WL; Wang XR; Liu YR; Gao WF; Zhang Q; Tan Q; Liu HJ; Zhou HG; Sun T; Yang C
Oncogene; 2019 Jan; 38(2):228-243. PubMed ID: 30087438
[TBL] [Abstract][Full Text] [Related]
20. [MIG7 Regulates the Vasculogenic Mimicry Formation in Hepatocellular Carcinoma then Effects the Metastasis Potential of HCC].
Qu B; Yu F; Sheng GN; Chen GN; Lü Q; Gu YJ; Guo L
Sichuan Da Xue Xue Bao Yi Xue Ban; 2017 May; 48(3):373-377. PubMed ID: 28616909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
